The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART

Biomedicine and Pharmacotherapy

Volumn 63, Issue 8, 2009, Pages 561-565

  Jevtovic Dj ^a   Vanovac, V ^a   Veselinovic M ^a   Salemovic D ^a   Ranin, J ^a   Stefanova, E ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Cognitive motor complex; HAART; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DRUG RESPONSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PATIENT COMPLIANCE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTECTION; RISK FACTOR; SERBIA; TREATMENT DURATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; ODDS RATIO; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; RNA, VIRAL; SERBIA; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 70349482973     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.09.015     Document Type: Article

References (22)

1. Jacobson M.A., and French M.A.H. Altered natural history of AIDS-related opportunistic infections in the era of potent combination anti-retroviral therapy. AIDS 12 Suppl. A (1998) S157-S163
2. Gea-Banacloche J.C., and Lane C.H. Immune reconstitution in HIV infection. AIDS 13 Suppl. A (1999) S25-S38
3. Carcelain G., Li T., and Autran B. Immune reconstitution under highly active antiretroviral therapy (HAART). AIDS Rev 1 (1999) 51-56
4. Dunić I., Vesić S., and Jevtović D.j. Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy. HIV Med 5 (2004) 50-54
5. McArthur J.C. HIV dementia: en evolving disease. J Neuroimmunol 157 (2004) 3-10
6. Doughtery R.H., Skolasky R.L., and McArthur J.C. Progression of HIV-associated dementia treated with HAART. AIDS Read 12 (2002) 69-74
7. CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41 RR-17 (1992) 1-19
8. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
9. McArthur J.C. Neurologic manifestations of AIDS. Medicine 66 (1987) 407-437
10. Pakker N.G., Kroon E.D.M.B., Roose M.T.L., Otto S.A., Hall D., Wit F.W.N.M., et al. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS study group. AIDS 13 (1999) 203-212
11. Jevtović D.j., Salemović D., Ranin J., Pešić I., Žerjav S., and Djurković-Djaković O. The dissociation between virological and immunological responses to HAART. Biomed Pharmacother 59 (2005) 446-451
12. Durant J., Clevenbergh P., Halfon P., Delgiudice P., Porsin S., Simonet P., et al. Drug-resistance genotyping in HIV-1 therapy: the VIRADEPT randomised controlled trial. Lancet 353 (1999) 2195-2199
13. Jevtović D.j., Salemović D., Ranin J., and Brmbolić B. Prognostic significance of index AIDS-defining diseases. Acta Infectol Yugoslav 1 (1996) 1-6
14. Sacktor N., McDermont M.P., Marder K., Schifitto G., Selnes O.A., McArthur J.C., et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neuroimmunol 8 (2002) 136-142
15. McArthur J.C., McDermott M.P., McClernon D., St Hillaire C., Conant K., Marder K., et al. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 61 (2004) 1687-1696
16. Gregory D.J., Correll P.K., Li Y., Koldor J.M., Cooper D.A., and Brew B.J. Change in AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13 (1999) 1249-1253
17. Valcour V., Shiramizu B., Shikuma C., Poff P., Waters M., Grove J., et al. Neurocognitive function among older compared to younger HIV-1 seropositive individuals. J Neuroimmunol (2002)
18. Becker J.T., Lopez O.L., and Aizenstein H.J. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 18 Suppl. 1 (2004) S11-S18
19. Clifford D.B., Evans S.R., Yag Y., and Gulick R.M. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS 19 Suppl. 3 (2005) S64-S71
20. Saksen N.K., and Smit T.K. HAART & the molecular biology of AIDS dementia complex. Indian J Med Res 121 (2005) 256-269
21. Enting R.H., Hoetelmns R.M., Lange J.M., Burger D.M., Beijnen J.H., Portegies P., et al. Antiretroviral drugs and the central nervous system. AIDS 12 (1998) 1941-1955
22. Price R.W., Yiannoutsos C.T., Cliford D.B., Zaborski L., Tselis A., Sidtis J.J., for the AIDS Clinical Trial Group, Neurological AIDS Research Consortium study team, et al. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS 13 (1999) 1677-1685